Ras-induced invasion and metastasis are regulated by a leukotriene B 4 receptor BLT2-linked pathway

Oncogene

Volumn 29, Issue 8, 2010, Pages 1167-1178

  Kim, E Y ^a   Seo, J M ^a   Cho, K J ^a   Kim, J H ^a  

^a Korea University   (South Korea)

Author keywords

H Ras; Leukotriene B4 receptor BLT2; Metastasis; MMP 9; ROS

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOTRIENE B4 RECEPTOR; PROTEIN BLT2; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; LUNG METASTASIS; LUNG NODULE; METASTASIS; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENES, RAS; HUMANS; LEUKOTRIENE B4; MATRIX METALLOPROTEINASE 9; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RAS PROTEINS; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, LEUKOTRIENE B4; TUMOR CELLS, CULTURED; UP-REGULATION;

MUS;

EID: 77649184896     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.412     Document Type: Article

References (50)

1. Behrend L, Henderson G, Zwacka RM. (2003). Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 31: 1441-1444.
2. Bjorklund M, Koivunen E. (2005). Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755: 37-69.
3. Bondy GP, Wilson S, Chambers AF. (1985). Experimental meta-static ability of H-ras-transformed NIH3T3 cells. Cancer Res 45: 6005-6009.
4. Bonfil RD, Sabbota A, Nabha S, Bernardo MM, Dong Z, Meng H et al. (2006). Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor. Int J Cancer 118: 2721-2726.
5. Bortuzzo C, Hanif R, Kashfi K, Staiano-Coico L, Shiff SJ, Rigas B. (1996). The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells. Biochim Biophys Acta 1300: 240-246.
6. Bos JL. (1989). ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689.
7. Brock TG, Peters-Golden M. (2007). Activation and regulation of cellular eicosanoid biosynthesis. ScientificWorldJournal 7: 1273-1284.
8. Campbell PM, Der CJ. (2004). Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin Cancer Biol 14: 105-114.
9. Cha YI, DuBois RN. (2007). NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med 58: 239-252.
10. Choi JA, Kim EY, Song H, Kim C, Kim JH. (2008). Reactive oxygen species are generated through a BLT2-linked cascade in Ras-transformed cells. Free Radic Biol Med 44: 624-634.
11. Choi JA, Lee JW, Kim H, Kim EY, Seo JM, Ko JS et al. (2009). Pro-survival of estrogen receptor-negative breast cancer cells is regulated by a BLT2-reactive oxygen species-linked signaling pathway. Carcinogenesis, doi:10.1093/carcin/bgp203.
12. Chun KS, Surh YJ. (2004). Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for che-moprevention. Biochem Pharmacol 68: 1089-1100.
13. Deryugina EI, Quigley JP. (2006). Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34.
14. Ding XZ, Hennig R, Adrian TE. (2003). Lipoxygenase and cycloox-ygenase metabolism: new insights in treatment and chemopreven-tion of pancreatic cancer. Mol Cancer 2: 10.
15. Ding XZ, Talamonti MS, Bell Jr RH, Adrian TE. (2005). A novel anti-pancreatic cancer agent, LY293111. Anticancer Drugs 16: 467-473.
16. Downward J. (2003). Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3: 11-22.
17. Giehl K. (2005). Oncogenic Ras in tumour progression and metastasis. Biol Chem 386: 193-205.
18. Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strongin AY et al. (2005). A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 25: 6401-6408.
19. Harris RE. (2007). Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer. Subcell Biochem 42: 93-126.
20. Hennig R, Osman T, Esposito I, Giese N, Rao SM, Ding XZ et al. (2008). BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation. Br J Cancer 99: 1064-1073.
21. Hennig R, Ventura J, Segersvard R, Ward E, Ding XZ, Rao SM et al. (2005). LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice. Neoplasia 7: 417-425.
22. Heukamp I, Kilian M, Gregor JI, Kiewert C, Schimke I, Kristiansen G et al. (2006). Impact of polyunsaturated fatty acids on hepato-pancreatic prostaglandin and leukotriene concentration in ductal pancreatic cancer-is there a correlation to tumour growth and liver metastasis? Prostaglandins Leukot Essent Fatty Acids 74: 223-233.
23. Hsu TC, Young MR, Cmarik J, Colburn NH. (2000). Activator protein 1 (AP-1)-and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic Biol Med 28: 1338-1348.
24. Iizuka Y, Yokomizo T, Terawaki K, Komine M, Tamaki K, Shimizu T. (2005). Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes. J Biol Chem 280: 24816-24823.
25. Kim GY, Lee JW, Cho SH, Seo JM, Kim JH. (2009). Role of the low-affinity leukotriene B4 receptor BLT2 in VEGF-induced angiogen-esis. Arterioscler Thromb Vasc Biol 6: 915-920.
26. Kruger A, Arlt MJ, Gerg M, Kopitz C, Bernardo MM, Chang M et al. (2005). Antimetastatic activity of a novel mechanism-based gelati-nase inhibitor. Cancer Res 65: 3523-3526.
27. Kumar CC, Bushel P, Mohan-Peterson S, Ramirez F. (1992). Regulation of smooth muscle alpha-actin promoter in ras-trans-formed cells: usefulness for setting up reporter gene-based assay system for drug screening. Cancer Res 52: 6877-6884.
28. Lee KW, Kim MS, Kang NJ, Kim DH, Surh YJ, Lee HJ et al. (2006). H-Ras selectively up-regulates MMP-9 and COX-2 through activation of ERK1/2 and NF-kappaB: an implication for invasive phenotype in rat liver epithelial cells. Int J Cancer 119: 1767-1775.
29. Mayoral R, Fernandez-Martinez A, Bosca L, Martin-Sanz P. (2005). Prostaglandin E2 promotes migration and adhesion in hepatocel-lular carcinoma cells. Carcinogenesis 26: 753-761.
30. Nie D, Che M, Grignon D, Tang K, Honn KV. (2001). Role of eicosanoids in prostate cancer progression. Cancer Metastasis Rev 20: 195-206.
31. Nikkola J, Vihinen P, Vuoristo MS, Kellokumpu-Lehtinen P, Kahari VM, Pyrhonen S. (2005). High serum levels of matrix metallopro-teinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin Cancer Res 11: 5158-5166.
32. Oft M, Akhurst RJ, Balmain A. (2002). Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat Cell Biol 4: 487-494.
33. Qiu H, Johansson AS, Sjostrom M, Wan M, Schroder O, Palmblad J et al. (2006). Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4. Proc Natl Acad Sci USA 103: 6913-6918.
34. Rocconi RP, Kirby TO, Seitz RS, Beck R, Straughn Jr JM, Alvarez RD et al. (2008). Lipoxygenase pathway receptor expression in ovarian cancer. Reprod Sci 15: 321-326.
35. Romano M, Claria J. (2003). Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB J 17: 1986-1995.
36. Shin EH, Lee HY, Bae YS. (2006). Leukotriene B4 stimulates human monocyte-derived dendritic cell chemotaxis. Biochem Biophys Res Commun 348: 606-611.
37. Su ZZ, Austin VN, Zimmer SG, Fisher PB. (1993). Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Oncogene 8: 1211-1219.
38. Subbaramaiah K, Norton L, Gerald W, Dannenberg AJ. (2002). Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3. J Biol Chem 277: 18649-18657.
39. Tong WG, Ding XZ, Hennig R, Witt RC, Standop J, Pour PM et al. (2002). Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Clin Cancer Res 8: 3232-3242.
40. Van Putten V, Refaat Z, Dessev C, Blaine S, Wick M, Butterfield L et al. (2001). Induction of cytosolic phospholipase A2 by oncogenic Ras is mediated through the JNK and ERK pathways in rat epithelial cells. J Biol Chem 276: 1226-1232.
41. Wang MT, Honn KV, Nie D. (2007). Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 26: 525-534.
42. Woo CH, You HJ, Cho SH, Eom YW, Chun JS, Yoo YJ et al. (2002). Leukotriene B(4) stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. J Biol Chem 277: 8572-8578.
43. Wu WS. (2006). The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev 25: 695-705.
44. Yang JQ, Zhao W, Duan H, Robbins ME, Buettner GR, Oberley LW et al. (2001). v-Ha-RaS oncogene upregulates the 92-kDa type IV collagenase (MMP-9) gene by increasing cellular superoxide production and activating NF-kappaB. Free Radic Biol Med 31: 520-529.
45. Yokomizo T, Kato K, Hagiya H, Izumi T, Shimizu T. (2001). Hydroxyeicosanoids bind to and activate the low affinity leuko-triene B4 receptor, BLT2. J Biol Chem 276: 12454-12459.
46. Yokomizo T, Kato K, Terawaki K, Izumi T, Shimizu T. (2000). A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med 192: 421-432.
47. Yokomizo T, Uozumi N, Takahashi T, Kume K, Izumi T, Shimizu T. (1995). Leukotriene A4 hydrolase and leukotriene B4 metabolism. J Lipid Mediat Cell Signal 12: 321-332.
48. Yoo MH, Song H, Woo CH, Kim H, Kim JH. (2004). Role of the BLT2, a leukotriene B4 receptor, in Ras transformation. Oncogene 23: 9259-9268.
49. Yoo MH, Woo CH, You HJ, Cho SH, Kim BC, Choi JE et al. (2001). Role of the cytosolic phospholipase A2-linked cascade in signaling by an oncogenic, constitutively active Ha-Ras isoform. J Biol Chem 276: 24645-24653.
50. Zampetaki A, Zhang Z, Hu Y, Xu Q. (2005). Biomechanical stress induces IL-6 expression in smooth muscle cells via Ras/Rac1-p38 MAPK-NF-kappaB signaling pathways. Am J Physiol Heart Circ Physiol 288: H2946-H2954.